Successful allogeneic engraftment of mismatched unrelated cord blood following a nonmyeloablative preparative regimen

Blood

Volumn 98, Issue 12, 2001, Pages 3486-3488

  Rizzieri, David A ^a   Long, Gwynn D ^a   Vredenburgh, James J ^a   Gasparetto, Christina ^a   Morris, Ashley ^a   Stenzel, Timothy T ^a   Davis, Patti ^a   Chao, Nelson J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; CD34 ANTIGEN; CISPLATIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; GANCICLOVIR; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA ANTIGEN; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE SODIUM SUCCINATE; METRONIDAZOLE; MITOXANTRONE; PACLITAXEL; PREDNISONE; RITUXIMAB; STEROID; THYMOCYTE ANTIBODY; VANCOMYCIN; VINCRISTINE;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; COLITIS; CYTOMEGALOVIRUS INFECTION; FLUORESCENCE IN SITU HYBRIDIZATION; GRAFT VERSUS HOST REACTION; HEMATOLOGICAL PARAMETERS; HLA TYPING; HUMAN; LEUKOCYTE COUNT; MALE; MANTLE CELL LYMPHOMA; NEUTROPENIA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME; UMBILICAL CORD BLOOD;

EID: 0035760326     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V98.12.3486     Document Type: Article

References (6)

1. Laughlin MJ, Rizzieri MJ, Rizzleri DA, Smith CA, et al. Hematologic engraftment and reconstitution of immune function post unrelated placental cord blood transplant in an adult with acute lymphocytic leukemia. Leuk Res. 1998;22:215-219.
2. Long G, Madan B, Kurtzberg J, et al. Unrelated umbilical cord blood transplants in adult patients with hematologic malignancies or genetic disorders [abstract]. Blood. 1999;94:2544a.
3. Khouri I, Keeting M, Korbling M, et al. Transplant lite: induction of graft versus malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor cell transplantation as treatment for lymphoid malignancies. J Clin Oncol. 1998;16:2817-2824.
4. Spitzer TR, McAfee SL, Sackstein R, et al. Induction of mixed chimerism and potent antitumor responses following non-myeloablative conditioning therapy and HLA-matched and mismatched donor bone marrow transplantation for refractory hematologic malignancies [abstract]. Blood. 1998;92:2134a.
5. Rizzieri DA, Long GD, Vredenburgh JJ, et al. Chimerism-mediated immunotherapy using Campath T-cell depleted peripheral blood stem cells with non-ablative therapy provides reliable, durable allogeneic engraftment [abstract]. Blood. 2000;96:2241a.
6. Nuckols JD, Rasheed BK, McGlennen RC, Bigner SH, Stenzel TT. Evaluation of an automated technique for assessment of marrow engraftment after allogeneic bone marrow transplantation using a commercially available kit. Am J Clin Pathol. 2000;113:135-140.